학술논문
Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
Document Type
Article
Author
Source
In: Lung Cancer . (Lung Cancer, 1 October 2016, 100:38-44)
Subject
Language
English
ISSN
18728332
01695002
01695002